Investor Presentation Q1 2018 Audited Results
II Introduction to the Company
...with a proven track record of success...
Launch: 2001-2005
Established in 2001 under the name
"Ibnsina Laborex" in partnership with
Pinault Printemps Redoute ("PPR")
through its subsidiary Eurapharma
Operational Sites
7
12k
Clients
2005
7.0%
EGP 665mn Revenue
IBNLaborex
SINA
HARMA
إبن سينا لابوركس فارما
In partnership with
PPR
KERING
IBN Pharma
ابن سينا فارما SINA
RIGHT ON TIME
Expansion: 2009-2012
Investment to add 15 distribution
centers & 5 offices, and enhance
efficiency through standardizing
operational processes
Operational Sites
27
30k
Clients
EGP 2.5bn
Revenue
2012
10.5%
2015
S
European Bank
for Reconstruction and Development
ibnsinapharma
Growth: 2013-Present
Capture market share through
implementing value-base differentiation
strategy & launch of new revenue
streams focusing on enhancing margins
Operational Sites
cfao
EURAPHARMA
Turnaround: 2006-2008
Management buy-out of PPR shares,
name changed to “Ibnsina Pharma“;
optimized cost structure & turned the
Company profitable
Operational Sites
56
c.41k
Clients
2017 Revenue
EGP 9.6bn
Market Share
7
16k
Clients
EGP 1.0bn
Revenue
ibnsinapharma
Source: IMS Health; Company Management
2008
8.8%
1Q18
19.5%
IN
6View entire presentation